CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Total	Common Stock Class A	Common Stock Class B	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehesive Income (Loss)
Balance, shares at Dec. 31, 2020		117,000,000
Balance, amount at Dec. 31, 2020	$ 1,167,619	$ 117,000	$ 0	$ 1,991,617	$ (942,994)	$ 1,996
Capital contributions to Yubo Beijing	127,164	$ 0	$ 0	127,164	0	0
Reverse acquisition of Yubo International Biotech Limited by Platinum International Biotech Co. Ltd., shares		1,177,885	4,447
Reverse acquisition of Yubo International Biotech Limited by Platinum International Biotech Co. Ltd., amount	0	$ 1,178	$ 4	(1,182)	0	0
Net loss for the three months ended March 31, 2021	(438,676)	0	0	0	(438,676)	0
Foreign currency translation adjustment	70,413	$ 0	$ 0	0	0	70,413
Balance, shares at Mar. 31, 2021		118,177,885	4,447
Balance, amount at Mar. 31, 2021	926,520	$ 118,178	$ 4	2,117,599	(1,381,670)	72,409
Balance, shares at Dec. 31, 2020		117,000,000
Balance, amount at Dec. 31, 2020	1,167,619	$ 117,000	$ 0	1,991,617	(942,994)	1,996
Net loss for the three months ended March 31, 2021	(808,683)
Foreign currency translation adjustment	83,535
Balance, shares at Jun. 30, 2021		118,177,885	4,447
Balance, amount at Jun. 30, 2021	569,634	$ 118,178	$ 4	2,117,599	(1,751,678)	85,531
Balance, shares at Mar. 31, 2021		118,177,885	4,447
Balance, amount at Mar. 31, 2021	926,520	$ 118,178	$ 4	2,117,599	(1,381,670)	72,409
Net loss for the three months ended March 31, 2021	(370,008)	0	0	0	(370,008)	0
Foreign currency translation adjustment	13,122	$ 0	$ 0	0	0	13,122
Balance, shares at Jun. 30, 2021		118,177,885	4,447
Balance, amount at Jun. 30, 2021	569,634	$ 118,178	$ 4	2,117,599	(1,751,678)	85,531
Balance, shares at Dec. 31, 2021		118,177,885	4,447
Balance, amount at Dec. 31, 2021	(131,198)	$ 118,178	$ 4	2,117,599	(2,485,432)	118,453
Net loss for the three months ended March 31, 2021	(578,948)	0	0	0	(578,948)	0
Foreign currency adjustment	(49,977)	$ 0	$ 0	0	0	(49,977)
Balance, shares at Mar. 31, 2022		118,177,885	4,447
Balance, amount at Mar. 31, 2022	(760,123)	$ 118,178	$ 4	2,117,599	(3,064,380)	68,476
Balance, shares at Dec. 31, 2021		118,177,885	4,447
Balance, amount at Dec. 31, 2021	(131,198)	$ 118,178	$ 4	2,117,599	(2,485,432)	118,453
Net loss for the three months ended March 31, 2021	(1,070,507)
Foreign currency translation adjustment	(49,927)
Balance, shares at Jun. 30, 2022		118,177,885	4,447
Balance, amount at Jun. 30, 2022	(1,251,632)	$ 118,178	$ 4	2,117,599	(3,555,939)	68,526
Balance, shares at Mar. 31, 2022		118,177,885	4,447
Balance, amount at Mar. 31, 2022	(760,123)	$ 118,178	$ 4	2,117,599	(3,064,380)	68,476
Net loss for the three months ended March 31, 2021	(491,559)	0	0	0	(491,559)	0
Foreign currency translation adjustment	50
Foreign currency adjustment	50	$ 0	$ 0	0	0	50
Balance, shares at Jun. 30, 2022		118,177,885	4,447
Balance, amount at Jun. 30, 2022	$ (1,251,632)	$ 118,178	$ 4	$ 2,117,599	$ (3,555,939)	$ 68,526